Bruker Corporation (BRKR)
USD 37.66
(-8.48%)
USD 37.66
(-8.48%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 436.9 Million USD | 11.46% |
| 2022 | 432.7 Million USD | 4.69% |
| 2021 | 413.3 Million USD | 66.45% |
| 2020 | 248.3 Million USD | -17.48% |
| 2019 | 300.9 Million USD | 14.67% |
| 2018 | 262.4 Million USD | 22.22% |
| 2017 | 214.7 Million USD | 21.16% |
| 2016 | 177.2 Million USD | 21.62% |
| 2015 | 145.7 Million USD | 38.24% |
| 2014 | 105.4 Million USD | -28.88% |
| 2013 | 148.2 Million USD | -5.0% |
| 2012 | 156 Million USD | 0.26% |
| 2011 | 155.6 Million USD | -0.06% |
| 2010 | 155.7 Million USD | 13.9% |
| 2009 | 136.7 Million USD | 26.34% |
| 2008 | 108.2 Million USD | 116.54% |
| 2007 | 49.96 Million USD | 62.96% |
| 2006 | 30.66 Million USD | 188.23% |
| 2005 | 10.63 Million USD | 1051.52% |
| 2004 | -1.11 Million USD | 88.45% |
| 2003 | -9.68 Million USD | -268.51% |
| 2002 | 5.74 Million USD | 75.53% |
| 2001 | 3.27 Million USD | 345.91% |
| 2000 | 734 Thousand USD | -76.91% |
| 1999 | 3.17 Million USD | 2074.04% |
| 1998 | -161 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 78.6 Million USD | -26.95% |
| 2024 Q3 | 28.3 Million USD | -8.1% |
| 2024 Q2 | 74.1 Million USD | -5.73% |
| 2023 Q2 | 86.2 Million USD | -29.75% |
| 2023 FY | 482.3 Million USD | 11.46% |
| 2023 Q1 | 122.7 Million USD | -6.34% |
| 2023 Q4 | 107.6 Million USD | -13.57% |
| 2023 Q3 | 124.5 Million USD | 44.43% |
| 2022 FY | 432.7 Million USD | 4.69% |
| 2022 Q1 | 96.5 Million USD | -23.05% |
| 2022 Q2 | 73.9 Million USD | -23.42% |
| 2022 Q3 | 131.3 Million USD | 77.67% |
| 2022 Q4 | 131 Million USD | -0.23% |
| 2021 FY | 413.3 Million USD | 66.45% |
| 2021 Q3 | 113.2 Million USD | 32.24% |
| 2021 Q2 | 85.6 Million USD | -3.93% |
| 2021 Q1 | 89.1 Million USD | -21.01% |
| 2021 Q4 | 125.4 Million USD | 10.78% |
| 2020 Q3 | 81.2 Million USD | 114.25% |
| 2020 FY | 248.3 Million USD | -17.48% |
| 2020 Q4 | 112.8 Million USD | 38.92% |
| 2020 Q2 | 37.9 Million USD | 131.1% |
| 2020 Q1 | 16.4 Million USD | -86.07% |
| 2019 FY | 300.9 Million USD | 14.67% |
| 2019 Q4 | 117.7 Million USD | 34.05% |
| 2019 Q1 | 41.9 Million USD | -60.62% |
| 2019 Q2 | 53.5 Million USD | 27.68% |
| 2019 Q3 | 87.8 Million USD | 64.11% |
| 2018 Q1 | 38.1 Million USD | -59.34% |
| 2018 Q2 | 48.8 Million USD | 28.08% |
| 2018 FY | 262.4 Million USD | 22.22% |
| 2018 Q4 | 106.4 Million USD | 53.98% |
| 2018 Q3 | 69.1 Million USD | 41.6% |
| 2017 Q1 | 37.6 Million USD | -51.11% |
| 2017 FY | 214.7 Million USD | 21.16% |
| 2017 Q3 | 49.9 Million USD | 48.96% |
| 2017 Q4 | 93.7 Million USD | 87.78% |
| 2017 Q2 | 33.5 Million USD | -10.9% |
| 2016 FY | 177.2 Million USD | 21.62% |
| 2016 Q4 | 76.9 Million USD | 67.54% |
| 2016 Q3 | 45.9 Million USD | 125.0% |
| 2016 Q2 | 20.4 Million USD | -40.0% |
| 2016 Q1 | 34 Million USD | -51.91% |
| 2015 Q3 | 28.2 Million USD | -10.76% |
| 2015 FY | 145.7 Million USD | 38.24% |
| 2015 Q4 | 70.7 Million USD | 150.71% |
| 2015 Q1 | 15.2 Million USD | -65.84% |
| 2015 Q2 | 31.6 Million USD | 107.89% |
| 2014 Q1 | 20.6 Million USD | -66.23% |
| 2014 Q3 | 4.9 Million USD | -86.16% |
| 2014 Q4 | 44.5 Million USD | 808.16% |
| 2014 FY | 105.4 Million USD | -28.88% |
| 2014 Q2 | 35.4 Million USD | 71.84% |
| 2013 FY | 148.2 Million USD | -5.0% |
| 2013 Q4 | 61 Million USD | 93.65% |
| 2013 Q3 | 31.5 Million USD | -27.59% |
| 2013 Q2 | 43.5 Million USD | 256.56% |
| 2013 Q1 | 12.2 Million USD | -68.88% |
| 2012 FY | 156 Million USD | 0.26% |
| 2012 Q1 | 34.4 Million USD | -35.94% |
| 2012 Q2 | 22.1 Million USD | -35.76% |
| 2012 Q3 | 60.3 Million USD | 172.85% |
| 2012 Q4 | 39.2 Million USD | -34.99% |
| 2011 FY | 155.6 Million USD | -0.06% |
| 2011 Q1 | 25.7 Million USD | -50.19% |
| 2011 Q3 | 37.5 Million USD | -3.1% |
| 2011 Q2 | 38.7 Million USD | 50.58% |
| 2011 Q4 | 53.7 Million USD | 43.2% |
| 2010 Q3 | 39.3 Million USD | 3.69% |
| 2010 Q2 | 37.9 Million USD | 40.89% |
| 2010 FY | 155.7 Million USD | 13.9% |
| 2010 Q4 | 51.6 Million USD | 31.3% |
| 2010 Q1 | 26.9 Million USD | -64.7% |
| 2009 Q1 | 14.3 Million USD | -70.64% |
| 2009 FY | 136.7 Million USD | 26.34% |
| 2009 Q4 | 76.2 Million USD | 193.08% |
| 2009 Q3 | 26 Million USD | 28.71% |
| 2009 Q2 | 20.2 Million USD | 41.26% |
| 2008 FY | 108.2 Million USD | 116.54% |
| 2008 Q4 | 48.69 Million USD | 221.8% |
| 2008 Q3 | 15.13 Million USD | -46.78% |
| 2008 Q2 | 28.43 Million USD | 78.45% |
| 2008 Q1 | 15.93 Million USD | -32.83% |
| 2007 Q1 | 7.75 Million USD | -51.32% |
| 2007 Q2 | 7.02 Million USD | -9.41% |
| 2007 FY | 49.96 Million USD | 62.96% |
| 2007 Q3 | 11.45 Million USD | 63.0% |
| 2007 Q4 | 23.72 Million USD | 107.05% |
| 2006 Q2 | 1.19 Million USD | -34.05% |
| 2006 Q1 | 1.8 Million USD | -57.54% |
| 2006 FY | 30.66 Million USD | 188.23% |
| 2006 Q3 | 6.98 Million USD | 485.41% |
| 2006 Q4 | 15.93 Million USD | 128.21% |
| 2005 FY | 10.63 Million USD | 1051.52% |
| 2005 Q2 | 911 Thousand USD | -64.12% |
| 2005 Q1 | 2.53 Million USD | 31.01% |
| 2005 Q3 | 2.92 Million USD | 221.41% |
| 2005 Q4 | 4.26 Million USD | 45.49% |
| 2004 Q1 | 1.96 Million USD | 3608.93% |
| 2004 Q3 | 255 Thousand USD | 104.83% |
| 2004 Q4 | 1.93 Million USD | 660.0% |
| 2004 Q2 | -5.27 Million USD | -368.55% |
| 2004 FY | -1.11 Million USD | 88.45% |
| 2003 Q2 | 340 Thousand USD | 169.25% |
| 2003 Q1 | -491 Thousand USD | -137.77% |
| 2003 Q4 | -56 Thousand USD | 98.99% |
| 2003 Q3 | -5.54 Million USD | -1731.47% |
| 2003 FY | -9.68 Million USD | -268.51% |
| 2002 Q1 | 1.34 Million USD | 27.29% |
| 2002 FY | 5.74 Million USD | 75.53% |
| 2002 Q4 | 1.3 Million USD | -51.07% |
| 2002 Q3 | 2.65 Million USD | 503.86% |
| 2002 Q2 | 440 Thousand USD | -67.36% |
| 2001 Q1 | 667 Thousand USD | 163.89% |
| 2001 FY | 3.27 Million USD | 345.91% |
| 2001 Q4 | 1.05 Million USD | 8.95% |
| 2001 Q3 | 972 Thousand USD | 69.04% |
| 2001 Q2 | 575 Thousand USD | -13.79% |
| 2000 Q2 | 448 Thousand USD | -40.47% |
| 2000 Q1 | 752.55 Thousand USD | 0.0% |
| 2000 Q4 | -1.04 Million USD | -280.94% |
| 2000 Q3 | 577 Thousand USD | 28.79% |
| 2000 FY | 734 Thousand USD | -76.91% |
| 1999 FY | 3.17 Million USD | 2074.04% |
| 1998 FY | -161 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 3142.267% |
| Cerus Corporation | -30.05 Million USD | 1553.765% |
| OrthoPediatrics Corp. | -25.76 Million USD | 1795.645% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 4213.417% |
| Talis Biomedical Corporation | -66.81 Million USD | 753.895% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 2626.018% |
| Inogen, Inc. | -109.38 Million USD | 499.411% |
| Spectral AI, Inc. | -12.98 Million USD | 3464.911% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 798.046% |
| CVRx, Inc. | -43.1 Million USD | 1113.619% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 12483.787% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 3615.449% |
| Orthofix Medical Inc. | -139.11 Million USD | 414.068% |
| Venus Concept Inc. | -28.3 Million USD | 1643.325% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 908.655% |
| Bioventus Inc. | -81.72 Million USD | 634.598% |
| BrainsWay Ltd. | -4.92 Million USD | 8967.465% |
| Envoy Medical, Inc. | -18.37 Million USD | 2478.205% |
| electroCore, Inc. | -18.8 Million USD | 2423.318% |
| IceCure Medical Ltd | -15.57 Million USD | 2904.956% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 1001.159% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 2630.109% |
| MaxCyte, Inc. | -48.29 Million USD | 1004.574% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 3754.461% |
| Nexalin Technology, Inc. | -5.69 Million USD | 7769.896% |
| PAVmed Inc | -68.79 Million USD | 735.075% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 872.413% |
| RxSight, Inc. | -50.08 Million USD | 972.317% |
| Sight Sciences, Inc. | -57.27 Million USD | 862.824% |
| SI-BONE, Inc. | -46.93 Million USD | 1030.941% |
| TELA Bio, Inc. | -44.07 Million USD | 1091.265% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 906.833% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 949.537% |
| LivaNova PLC | -68.49 Million USD | 737.829% |
| 908 Devices Inc. | -42.75 Million USD | 1121.797% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 351.968% |
| Nemaura Medical Inc. | -9.59 Million USD | 4653.302% |
| NeuroPace, Inc. | -27.17 Million USD | 1707.787% |
| LENSAR, Inc. | -12.22 Million USD | 3672.655% |
| Apyx Medical Corporation | -17.25 Million USD | 2631.433% |
| Cutera, Inc. | -156.23 Million USD | 379.652% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 5177.871% |
| BioSig Technologies, Inc. | -28.51 Million USD | 1632.337% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 598.522% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 2046.449% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | -291.747% |
| Axonics, Inc. | -26.05 Million USD | 1776.709% |
| Outset Medical, Inc. | -169.77 Million USD | 357.348% |
| IRIDEX Corporation | -10 Million USD | 4465.944% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 500.202% |
| IRadimed Corporation | 20.03 Million USD | -2080.634% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 5398.97% |
| INVO Bioscience, Inc. | -6.76 Million USD | 6556.184% |
| Telesis Bio, Inc. | -35.15 Million USD | 1342.959% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -2948.849% |
| Varex Imaging Corporation | 32.1 Million USD | -1261.059% |
| Quipt Home Medical Corp. | 3.91 Million USD | -11048.252% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 3700.923% |
| Pulmonx Corporation | -61.93 Million USD | 805.417% |
| Dynatronics Corporation | -2.27 Million USD | 19320.888% |
| Modular Medical, Inc. | -17.52 Million USD | 2592.441% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 3084.493% |
| Semler Scientific, Inc. | 22.25 Million USD | -1863.066% |
| InMode Ltd. | 195.66 Million USD | -123.296% |
| Cytosorbents Corporation | -31.2 Million USD | 1499.905% |
| DexCom, Inc. | 597.7 Million USD | 26.903% |
| Align Technology, Inc. | 643.33 Million USD | 32.089% |
| Viveve Medical, Inc. | -21.55 Million USD | 2127.096% |
| ZimVie Inc. | -30.93 Million USD | 1512.134% |
| Movano Inc. | -29.69 Million USD | 1571.539% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 1669.043% |
| Nexalin Technology, Inc. | -5.69 Million USD | 7769.896% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 12483.787% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 287.326% |
| Profound Medical Corp. | -28.61 Million USD | 1626.768% |
| Insulet Corporation | 220 Million USD | -98.591% |
| enVVeno Medical Corporation | -25.23 Million USD | 1831.12% |
| Surmodics, Inc. | -5.64 Million USD | 7839.593% |
| iCAD, Inc. | -7.68 Million USD | 5782.143% |
| Nuwellis, Inc. | -17.63 Million USD | 2578.162% |
| Biotricity, Inc. | -8.82 Million USD | 5048.875% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 449.07% |
| Aethlon Medical, Inc. | -12.63 Million USD | 3557.426% |
| InspireMD, Inc. | -21.14 Million USD | 2166.405% |
| PAVmed Inc. | -68.79 Million USD | 735.075% |
| BIOLASE, Inc. | -17.93 Million USD | 2535.747% |
| Beyond Air, Inc. | -63 Million USD | 793.426% |
| FONAR Corporation | 16.53 Million USD | -2542.216% |
| AxoGen, Inc. | -21.46 Million USD | 2135.691% |
| Vivani Medical, Inc. | -26.96 Million USD | 1720.248% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -2321.706% |
| Inari Medical, Inc. | -14.03 Million USD | 3213.597% |
| UFP Technologies, Inc. | 57.66 Million USD | -657.665% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 8966.385% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 7028.575% |
| Tenon Medical, Inc. | -15.72 Million USD | 2878.025% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 5945.598% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 1123.036% |
| AdaptHealth Corp. | -598.4 Million USD | 173.011% |
| Sintx Technologies, Inc. | -13.35 Million USD | 3370.699% |
| NanoVibronix, Inc. | -3.43 Million USD | 12815.367% |
| Quanterix Corporation | -49.7 Million USD | 979.057% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 3700.923% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 114471.728% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 230.626% |
| TransMedics Group, Inc. | -28.72 Million USD | 1620.869% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 1950.33% |
| NeuroMetrix, Inc. | -7.15 Million USD | 6209.19% |
| Hyperfine, Inc. | -48.11 Million USD | 1008.033% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 771.885% |
| Biomerica, Inc. | -6.36 Million USD | 6961.944% |
| Bone Biologics Corporation | -9.42 Million USD | 4733.92% |
| AVITA Medical, Inc. | -40.4 Million USD | 1181.38% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 4337.134% |
| Silk Road Medical, Inc | -59.27 Million USD | 837.123% |